Telix Pharmaceuticals (ASX:TLX) - Key People
ASX:TLX · Directors, executives and key personnel · 12 month lookback
Dr Christian Behrenbruch
Current
Managing Director & Group Chief Executive Officer
Mentioned in
Telix bets US$1.65 billion on ITM and a faster route into radiopharmaceutical therapies
21 Sept 2026
Market Wrap - Week 34 (17 Aug -> 21 Aug) 2026
22 Aug 2026
Healthcare Wrap - Week 34 (17 Aug -> 21 Aug) 2026
22 Aug 2026
Telix Pharmaceuticals Posts $38.3M Profit on 22% Revenue Surge, Boosts R&D and Partners with Regeneron
20 Aug 2026
Also Mentioned
People named in Telix Pharmaceuticals (ASX:TLX) articles over the last 12 months, by frequency.
Annie Kasparian
· 23 articles
Kyahn Williamson
· 23 articles
David N. Cade
· 17 articles
Charlene Jaw
· 16 articles
Eliza Schleifstein
· 15 articles
David Gill
· 9 articles
Mark Nelson
· 9 articles
Kevin Richardson
· 8 articles
Willi Jellison
· 6 articles
Marie McDonald
· 6 articles
Tiffany Olson
· 6 articles
Maria Rivas
· 6 articles
Jann Skinner
· 6 articles
Neeraj Agarwal
· 5 articles
Darren Smith
· 4 articles
Christian Behrenbruch - Managing Director and Group CEO, Telix
· 3 articles
Andrew Cavey - Chief Executive Officer, ITM
· 3 articles
Darren Smith - Group Chief Financial Officer, Telix
· 3 articles
Barbara Weber - proposed Telix director
· 3 articles
Professor Louise Emmett
· 3 articles